About this episode
Sam Harris speaks with Robin Carhart-Harris about psychedelic research and its therapeutic potential.
Sam Harris speaks with Robin Carhart-Harris about psychedelic research and its therapeutic potential. They discuss the current state of the field, the FDA denial of MDMA-assisted therapy for PTSD, the critical role of set and setting, risks for vulnerable populations, the REBUS model of how psychedelics work on the brain, the default mode network and ego dissolution, microdosing, the neuroscience of consciousness, DMT entities, and other topics. If the Making Sense podcast logo in your player is BLACK, you can SUBSCRIBE to gain access to all full-length episodes at samharris.org/subscribe .
People in this episode
Host: Sam Harris
Guest: Robin Carhart-Harris
Topics covered
- psychedelic research
- therapeutic potential
- PTSD treatment
- set and setting
- neuroscience
- consciousness
- ego dissolution
Keywords
- psychedelics
- therapy
- MDMA
- PTSD
- microdosing
- consciousness
- neuroscience
Mentioned in this episode
Organizations: FDA
Books & works: MDMA-assisted therapy, REBUS model, default mode network, ego dissolution, microdosing, neuroscience of consciousness, DMT entities
More episodes of Making Sense with Sam Harris
- #480 — The Economics of Everything · June 12, 2026 · 25 min
- #479 — When Robots Take Over · June 4, 2026 · 15 min
- #477 — More From Sam: Iran's Unraveling, The Gaza Information War, AI-Generated Music, and More · May 26, 2026 · 22 min
- #476 — The Bittersweet Age · May 20, 2026 · 23 min
- #475 — The Hard Problem of Consciousness · May 12, 2026 · 26 min
- #474 — More From Sam: Hasan Piker, Islamism, Making Sense Community, and More · May 7, 2026 · 17 min
Explore listener stats, chart rankings, contacts and more on the Making Sense with Sam Harris podcast page.